← 返回

NK 细胞分泌的 IFN-γ 和 TNF-α 介导肺干细胞样肿瘤分化并导致肿瘤对化疗药物的敏感性

英文原题:Natural Killer Cell-Secreted IFN-γ and TNF-α Mediated Differentiation in Lung Stem-like Tumors, Leading to the Susceptibility of the Tumors to Chemotherapeutic Drugs.

查看英文原题

Natural Killer Cell-Secreted IFN-γ and TNF-α Mediated Differentiation in Lung Stem-like Tumors, Leading to the Susceptibility of the Tumors to Chemotherapeutic Drugs.

PubMed 2025/01/10(内容时间) Cells Q2 · IF 6(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

中文摘要

我们证明,与分化的肺癌细胞系(H292)相比,自然杀伤(NK)细胞对肺癌干样细胞(hA549)诱导出更高的细胞毒性。来自分裂无能NK细胞(经IL-2和抗CD16 mAb处理的NK细胞)的上清液诱导hA549分化。分化的肺癌细胞系(H292)和NK细胞分化的hA549表现出降低的NK细胞介导的细胞毒性,但对化疗药物表现出更高的敏感性。这一发现验证了我们之前的报告,即NK细胞和化疗药物杀伤肿瘤的水平分别与肿瘤分化的阶段和水平直接和间接相关。

我们还证明了IFN-和TNF-在诱导肿瘤分化中的作用。当我们使用针对IFN-和TNF-的抗体时,NK细胞上清液或IFN-和TNF-诱导的肿瘤分化被阻断。

因此,NK细胞释放的IFN-和TNF-在诱导肿瘤分化中发挥重要作用,导致肿瘤对化疗药物的敏感性增加。我们还观察到MHC-I类抗体在CSCs与分化肿瘤中的不同作用。用抗MHC-I类抗体处理降低了hA549肿瘤中NK细胞介导的细胞毒性,而当分化肿瘤用针对MHC-I类的抗体处理时,NK细胞介导的细胞毒性增加。

展开英文摘要原文

We demonstrate that natural killer (NK) cells induce a higher cytotoxicity against lung cancer stem-like cells (hA549) compared to differentiated lung cancer cell lines (H292). The supernatants from split-anergized NK cells (IL-2 and anti-CD16 mAb-treated NK cells) induced differentiation in hA549.

Differentiated lung cancer cell line (H292) and NK cells differentiated hA549 expressed reduced NK cell-mediated cytotoxicity but expressed higher sensitivity to chemotherapeutic drugs. This finding validated our previous reports demonstrating that the levels of tumor killing by NK cells and by chemotherapeutic drugs correlate directly and indirectly, respectively, with the stage and levels of tumor differentiation.

We also demonstrate the role of IFN- and TNF- in inducing tumor differentiation. NK cells' supernatants or IFN- and TNF- -induced tumor differentiation was blocked when we used antibodies against IFN- and TNF- .

Therefore, IFN- and TNF- released from NK cells play a significant role in differentiating tumors, resulting in increased susceptibility of tumors to chemotherapeutic drugs.

We also observed the different effects of MHC-class I antibodies in CSCs vs. differentiated tumors. Treatment with anti-MHC-class I decreased NK cell-mediated cytotoxicity in hA549 tumors, whereas it increased NK cell-mediated cytotoxicity when differentiated tumors were treated with antibodies against MHC-class I.

论文信息

作者
Kaur K、Celis AP、Jewett A
单位
Division of Oral Biology and Medicine, The Jane and Jerry Weintraub Center for Reconstructive Biotechnology, University of California School of Dentistry, 10833 Le Conte Ave, Los Angeles, CA 90095, USA.United States
文献类型
非美国政府资助研究 · 美国 NIH 资助研究
期刊
Cells2025 Jan 10
原文标识
PubMed 39851518 · DOI 10.3390/cells14020090